• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABO/Rh血型不影响接受根治性前列腺切除术患者的临床病理肿瘤特征或肿瘤学结局。

AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.

作者信息

Oh Su Jung, Mandel Philipp, Chun Felix K H, Tennstedt Pierre, Peine Sven, Hohenhorst Jan Lukas, Hiller Jens, Graefen Markus, Tilki Derya, Steuber Thomas

机构信息

Martini Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Department of Anatomy and Experimental Morphology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Front Surg. 2017 Dec 18;4:75. doi: 10.3389/fsurg.2017.00075. eCollection 2017.

DOI:10.3389/fsurg.2017.00075
PMID:29326944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5741602/
Abstract

OBJECTIVES

AB0 blood group is an inherited characteristic that has been associated with the incidence as well as the prognosis of several malignancies. The aim of the current study was to clarify the role of the blood group in cancer epidemiology and clinical outcome of patients with prostate cancer (PCa).

METHODS

Data from 3,574 patients undergoing radical prostatectomy between 2009 and 2010 at a single European institution were retrospectively analyzed. The correlation of AB0 and Rhesus blood group with PCa-related characteristics and oncological outcome were evaluated using univariable and multivariable Cox proportional hazard models.

RESULTS

Median follow-up was 36.9 months. The overall distributions of AB0, as well as Rhesus blood groups among patients with PCa, did not differ from the distribution observed in the normal population. There was no significant association between AB0/Rhesus blood groups and Gleason score, prostate volume, surgical margin, pT-stage, pN-status, or preoperative prostate-specific antigen level. In multivariable Cox regression analysis, no statistically significant correlation between AB0/Rhesus group and biochemical recurrence was observed (all  > 0.05).

CONCLUSION

Our data suggest no relevant association of AB0/Rhesus blood group with adverse clinicopathological tumor characteristics or oncological outcome after surgery in contrast to several other malignancies.

摘要

目的

ABO血型是一种遗传特征,与多种恶性肿瘤的发病率及预后相关。本研究旨在阐明血型在前列腺癌(PCa)患者的癌症流行病学及临床结局中的作用。

方法

回顾性分析了2009年至2010年期间在一家欧洲机构接受根治性前列腺切除术的3574例患者的数据。使用单变量和多变量Cox比例风险模型评估ABO和Rh血型与PCa相关特征及肿瘤学结局的相关性。

结果

中位随访时间为36.9个月。PCa患者中ABO及Rh血型的总体分布与正常人群中观察到的分布无差异。ABO/Rh血型与 Gleason评分、前列腺体积、手术切缘、pT分期、pN状态或术前前列腺特异性抗原水平之间无显著关联。在多变量Cox回归分析中,未观察到ABO/Rh血型与生化复发之间存在统计学显著相关性(所有P>0.05)。

结论

与其他几种恶性肿瘤不同,我们的数据表明ABO/Rh血型与不良临床病理肿瘤特征或术后肿瘤学结局无相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6c/5741602/8fd887e744ec/fsurg-04-00075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6c/5741602/5251811f90f0/fsurg-04-00075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6c/5741602/8fd887e744ec/fsurg-04-00075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6c/5741602/5251811f90f0/fsurg-04-00075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6c/5741602/8fd887e744ec/fsurg-04-00075-g002.jpg

相似文献

1
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.ABO/Rh血型不影响接受根治性前列腺切除术患者的临床病理肿瘤特征或肿瘤学结局。
Front Surg. 2017 Dec 18;4:75. doi: 10.3389/fsurg.2017.00075. eCollection 2017.
2
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.ABO和恒河猴血型系统对接受根治性肾输尿管切除术治疗上尿路尿路上皮癌患者肿瘤学结局的影响。
Urol Oncol. 2017 Dec;35(12):671.e17-671.e23. doi: 10.1016/j.urolonc.2017.08.007. Epub 2017 Sep 8.
3
The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.AB0和恒河猴血型系统对接受根治性膀胱切除术的膀胱癌患者治疗结果的影响。
World J Urol. 2015 Nov;33(11):1769-76. doi: 10.1007/s00345-015-1531-6. Epub 2015 Mar 18.
4
Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.术前血脂水平在临床局限性前列腺癌根治性前列腺切除术患者中的预后作用
Prostate. 2017 Apr;77(5):549-556. doi: 10.1002/pros.23296. Epub 2017 Jan 17.
5
Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.在局限性前列腺癌中,根治性前列腺切除术标本中的三级Gleason分级模式与下一个更高Gleason评分组相比,预后更差。
Urol Oncol. 2018 Apr;36(4):158.e1-158.e6. doi: 10.1016/j.urolonc.2017.12.003. Epub 2017 Dec 27.
6
AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.AB0 血型和 Rh 因子表达作为上皮性卵巢癌患者的预后参数 - 一项回顾性多中心研究。
BMC Cancer. 2018 Apr 19;18(1):447. doi: 10.1186/s12885-018-4289-6.
7
Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml.术前前列腺特异性抗原<2.5ng/ml 和 2.5-4ng/ml 的男性接受根治性前列腺切除术的长期肿瘤学结果。
Urol Oncol. 2013 Nov;31(8):1527-32. doi: 10.1016/j.urolonc.2012.06.003. Epub 2012 Jul 12.
8
[Perioperative parameters and prognosis analysis of patients aged 80 years or older treated with radical prostatectomy for prostate cancer].[80岁及以上前列腺癌患者行根治性前列腺切除术的围手术期参数及预后分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Oct 18;50(5):822-827.
9
Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.保留Retzius间隙的机器人辅助根治性前列腺切除术后生化复发的预测因素:359例患者分析,中位随访期26个月
Int J Urol. 2018 Dec;25(12):1006-1014. doi: 10.1111/iju.13808. Epub 2018 Oct 1.
10
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.耻骨后根治性前列腺切除术后早期前列腺特异性抗原复发:基于术前和术后肿瘤特征的预测
Eur Urol. 1999;36(1):21-30. doi: 10.1159/000019922.

引用本文的文献

1
Impact of Sarcopenia on Functional and Oncological Outcomes After Radical Prostatectomy.肌少症对前列腺癌根治术后功能及肿瘤学结局的影响
Front Surg. 2021 Feb 3;7:620714. doi: 10.3389/fsurg.2020.620714. eCollection 2020.

本文引用的文献

1
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).ABO血型等位基因与前列腺癌风险:来自乳腺癌和前列腺癌队列联盟(BPC3)的结果。
Prostate. 2015 Nov;75(15):1677-81. doi: 10.1002/pros.23035. Epub 2015 Aug 13.
2
Associations between ABO blood groups and biochemical recurrence after radical prostatectomy.根治性前列腺切除术后ABO血型与生化复发之间的关联。
Int J Clin Exp Med. 2015 Feb 15;8(2):2642-8. eCollection 2015.
3
Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population.
ABO 组织血型和 FUT 基因座的变异与欧洲人群弥漫型和肠型胃癌风险。
Int J Cancer. 2015 Feb 15;136(4):880-93. doi: 10.1002/ijc.29034. Epub 2014 Jul 1.
4
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
5
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.ABO血型对原发性非肌层浸润性膀胱癌患者预后的影响。
J Urol. 2014 May;191(5):1238-43. doi: 10.1016/j.juro.2013.11.106. Epub 2013 Dec 11.
6
Prostate cancer: Non-O blood type is VTE risk factor after radical prostatectomy.前列腺癌:非O型血是前列腺癌根治术后静脉血栓栓塞症的风险因素。
Nat Rev Urol. 2013 Dec;10(12):680. doi: 10.1038/nrurol.2013.255. Epub 2013 Nov 5.
7
Blood group determinates incidence for pancreatic cancer in Germany.血型决定德国胰腺癌的发病率。
Front Physiol. 2013 May 24;4:118. doi: 10.3389/fphys.2013.00118. eCollection 2013.
8
Model-based patterns in prostate cancer mortality worldwide.全球前列腺癌死亡率的基于模型的模式。
Br J Cancer. 2013 Jun 11;108(11):2354-66. doi: 10.1038/bjc.2013.217. Epub 2013 May 9.
9
Serum antibodies to blood group A predict survival on PROSTVAC-VF.血清抗 A 血型抗体预测 PROSTVAC-VF 的生存情况。
Clin Cancer Res. 2013 Mar 1;19(5):1290-9. doi: 10.1158/1078-0432.CCR-12-2478. Epub 2013 Jan 29.
10
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.神经血管结构毗邻冷冻切片检查(NeuroSAFE)增加了在开放性和机器人辅助腹腔镜根治性前列腺切除术中保留神经的频率,并减少了阳性手术切缘:11069 例连续患者的经验。
Eur Urol. 2012 Aug;62(2):333-40. doi: 10.1016/j.eururo.2012.04.057. Epub 2012 May 10.